Active implantable medical devices are any active medical devices considered to be totally or partially introduced medically into the medical intervention into a natural orifice designed to remain after the procedure. According to BlueQuark's, the Global Active Implantable Medical Devices Market is expected to witness a significant growth rate during the forecasted period. Factors such as the increasing burden of neurological and cardiovascular diseases and investments and funds to develop technologically advanced products are expected to drive the demand for the Active Implantable Medical Devices Market in the forecasted period. Further, increasing chronic diseases coupled with the advancements in active implantable medical devices are expected to drive the demand for the Active Implantable Medical Devices Market in the forecasted period. Furthermore, the investments and funds to develop technologically advanced products and favourable reimbursement scenarios for ENT procedures in developed countries are expected to drive the demand for the Active Implantable Medical Devices Market in the forecasted period. However, increasing demand for non-invasive procedures, issues related to implantable devices, and the high cost are anticipated to impede the Active Implantable Medical Devices market growth.

The increase in the burden of cardiovascular diseases across the globe is one of the significant factors fueling the growth of the implantable medical devices market. The implantable cardiac pacemakers are of three major types: single-chamber, dual-chamber, and biventricular pacemakers. The segment's growth can be attributed to reduced post-surgical complications and multiple leads to ensure normal heart physiology. The increasing prevalence of cardiovascular diseases, high obesity rates, and favourable reimbursement environments are the primary factors driving market growth. The development can be attributed with the growing incidence of cardiovascular diseases, technologically advanced devices, and demand for these devices in developing countries. Implantable cardioverter defibrillators are further segmented into single-chamber, dual-chamber, and biventricular pacemaker devices. Heart rhythms can be controlled, functional electrical stimulation of nerves can be offered, glaucoma sensors can be used, hypertension can be monitored, and bladder and cranial pressure may be observed. Many wireless medical devices convey receivers in the region that are connected to cellular networks, high-speed internet access, and landlines. Cardiovascular machines, Parkinson's disease, spasticity, epilepsy, and individuals with hearing or vision disability are among the diseases for which devices are utilized. The surge in demand for active implantable medical devices is primary attributed to the growing burden of diseases such as neurological disorders, cardiovascular disorders, hearing disability, and others worldwide due to the ever-increasing old age population. In addition, the surge in product approvals, and the elevating investment and funds by the companies for the growth of active implantable devices, among others, are also the features responsible for the global market growth in the forecasted period.

 North America is expected to occupy a significant share of the overall active implantable medical devices market during the forecasted period. This domination is owing to the surge in cases of various heart-associated disorders, rise in neurodegenerative diseases, increase in population with chronic pain, increasing hearing disability, and others. Additionally, favourable reimbursement scenarios and a well-established healthcare system are also factors that are driving the market growth. The rapidly ageing population, increasing prevalence of chronic diseases, and technological development in implantable medical systems contribute to market growth. In addition, the market is increasing due to rising consumer awareness of advanced medical device technologies and neurostimulator applications. Implants are entered into the human body either fully or partially using surgical or medicinal procedures. The device can be joined permanently or temporarily and removed depending on the situation. Age-related diseases have become more common as people's life expectancies have surged. This has further improved the need for different life-extension medical devices, including novel therapies, prostheses, implants, and long-term pharmaceutical use. Various materials create implantable devices, including tissues, metals, bones, polymers, skin, and ceramics. The emergence of innovative implantable devices with improved performance and effortless operative procedures is awaited to support the market's growth. The rising cardiovascular disease cases also contribute a lot to the market's success. An increasing number of medical research activities to make advanced and ergonomically advanced technologies due to a widening number of diseases offer lucrative growth globally. The technology behind the devices has been observed as a revolution in medical history and has saved and secured many lives, hence the belief that doctors and the public hold in it are enough to propel the market.

Some of the market's key players are Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, Integra LifeSciences Holdings Corporation, and Cardinal Health, Inc.

In August 2022, Medtronic plc launched an investigational extravascular implantable cardioverter defibrillator (EV ICD) system defibrillator with the lead placed under the breastbone, outside of the heart, and veins attained a defibrillation success rate of 98.7% and met its safety endpoints in a global clinical trial.

In February 2022, Abbott launched the patient implants of a dual-chamber lead-free pacemaker system as part of its AVEIR DR i2i pivotal clinical. The implant of Abbott's investigational over dual-chamber leadless pacemaker represents an important technological milestone for leadless pacing advancement and is the first to occur worldwide within the pivotal trial.

Global Active Implantable Medical Devices Market report provides deep insight into the Industrial market's current and future state across various regions. The study comprehensively analyses the Active Implantable Medical Devices market by segmenting based on the By Product (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop Recorders, Neurostimulators, Implantable Hearing Devices, Others), and Geography (Asia-Pacific, North America, Europe, South America, and Middle-East and Africa). The report examines the market drivers and restraints and the impact of Covid-19 on market growth in detail. The study covers and includes emerging market trends, developments, opportunities, and challenges in the industry. This report also covers extensively researched competitive landscape sections with prominent companies and profiles, including their market shares and projects.